Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.135 USD | -5.29% | +18.77% | +212.32% |
18/04 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
06/03 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+212.32% | 133M | |
+8.90% | 105B | |
-0.62% | 104B | |
+5.79% | 22.94B | |
-12.62% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.21% | 16.96B | |
+7.72% | 14.16B | |
+37.79% | 12.63B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Sector Update: Health Care Stocks Fade Late, Finish in the Red